Dr. Bob Humphries


Bob Humphries is a pharmacologist with over 30 years’ experience in the pharmaceutical industry. As the Project Head at AstraZeneca, he led the discovery and early progression of the anti-thrombotic compounds cangrelor and ticagrelor. He is the co-founder of the inhaled drug consultancy Adhale, and Director of several companies including TherapeutAix, Platelet Solutions and Oncotherics.